STAAR Surgical Company  

(Public, NASDAQ:STAA)   Watch this stock  
Find more results for STAA
+0.31 (3.59%)
Jul 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.62 - 8.96
52 week 4.84 - 13.73
Open 8.71
Vol / Avg. 142,741.00/130,169.00
Mkt cap 335.68M
P/E     -
Div/yield     -
EPS -0.24
Shares 38.85M
Beta 0.59
Inst. own 82%
Jul 29, 2015
Q2 2015 STAAR Surgical Company Earnings Call - 4:30PM EDT - Add to calendar
Jul 29, 2015
Q2 2015 STAAR Surgical Company Earnings Release - 4:00PM EDT - Add to calendar
Jul 8, 2015
STAAR Surgical Company Annual Shareholders Meeting
May 7, 2015
STAAR Surgical Company at Deutsche Bank Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin -12.41% -11.19%
Operating margin -8.01% -10.70%
EBITD margin - -7.42%
Return on average assets -16.22% -13.89%
Return on average equity -25.56% -22.10%
Employees 300 -
CDP Score - -


1911 Walker Ave
United States - Map
+1-626-3037902 (Phone)
+1-626-3032962 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company's principal products are intraocular lenses (IOLs) and implantable Collamer lenses (ICLs). IOLs are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts, and include the Company's lines of silicone and Collamer IOLs and the Preloaded Injector (a silicone or acrylic IOL preloaded into a single-use disposable injector). ICLs, consisting of the Company's ICL and Toric implantable collamer lenses (TICL), are intraocular lenses used to correct refractive conditions, such as myopia (near-sightedness), hyperopia (far-sightedness) and astigmatism. The Company operates under the brands STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX nanoPOINT, Epiphany and AquaFlow. Collamer is the brand name for its collagen copolymer lens material.

Officers and directors

Mark B. Logan Independent Chairman of the Board
Age: 76
Bio & Compensation  - Reuters
Caren L. Mason President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Stephen P. Brown Chief Financial Officer, Vice President
Age: 55
Bio & Compensation  - Reuters
Hans-Martin Blickensdoerfer President, International Commercial Operations
Age: 50
Bio & Compensation  - Reuters
Deborah J. Andrews Chief Accounting Officer, Vice President
Age: 57
Bio & Compensation  - Reuters
Samuel J. Gesten Vice President, General Counsel, Corporate Compliance Officer and Secretary
Age: 53
Bio & Compensation  - Reuters
Donald Lee Fagen Vice President - North American Sales
Age: 61
Bio & Compensation  - Reuters
James E. Francese Vice President - Global Marketing
Age: 50
Bio & Compensation  - Reuters
William Walter Goodmen Vice President - Global Human Resources
Age: 60
Bio & Compensation  - Reuters
Paul Hambrick Vice President -IOL Manufacturing
Age: 52
Bio & Compensation  - Reuters